Concert Pharmaceuticals Stock Gross Profit
| CNCEDelisted Stock | USD 8.37 0.01 0.12% |
Concert Pharmaceuticals fundamentals help investors to digest information that contributes to Concert Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Concert Stock. The fundamental analysis module provides a way to measure Concert Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Concert Pharmaceuticals stock.
Concert |
Concert Pharmaceuticals Company Gross Profit Analysis
Concert Pharmaceuticals' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Concert Pharmaceuticals Gross Profit | (54.98 M) |
Most of Concert Pharmaceuticals' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Concert Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Concert Pharmaceuticals reported (54.98 Million) of gross profit. This is 102.45% lower than that of the Biotechnology sector and 105.78% lower than that of the Health Care industry. The gross profit for all United States stocks is 100.2% higher than that of the company.
Concert Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Concert Pharmaceuticals' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Concert Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Concert Pharmaceuticals by comparing valuation metrics of similar companies.Concert Pharmaceuticals is currently under evaluation in gross profit category among its peers.
Concert Fundamentals
| Return On Equity | -1.09 | |||
| Return On Asset | -0.39 | |||
| Operating Margin | (2.88) % | |||
| Current Valuation | 86.63 M | |||
| Shares Outstanding | 48.02 M | |||
| Shares Owned By Insiders | 3.77 % | |||
| Shares Owned By Institutions | 77.05 % | |||
| Number Of Shares Shorted | 1.08 M | |||
| Price To Earning | 3.08 X | |||
| Price To Book | 1.67 X | |||
| Price To Sales | 7.05 X | |||
| Revenue | 32.58 K | |||
| Gross Profit | (54.98 M) | |||
| EBITDA | 1.4 M | |||
| Net Income | (80.05 K) | |||
| Cash And Equivalents | 154.57 M | |||
| Cash Per Share | 3.22 X | |||
| Total Debt | 14.51 M | |||
| Debt To Equity | 0.11 % | |||
| Current Ratio | 10.03 X | |||
| Book Value Per Share | 2.78 X | |||
| Cash Flow From Operations | (55.15 M) | |||
| Short Ratio | 0.26 X | |||
| Earnings Per Share | (3.17) X | |||
| Target Price | 11.67 | |||
| Number Of Employees | 64 | |||
| Beta | 0.49 | |||
| Market Capitalization | 401.95 M | |||
| Total Asset | 165.32 M | |||
| Retained Earnings | (210.05 M) | |||
| Working Capital | 137.48 M | |||
| Current Asset | 144.11 M | |||
| Current Liabilities | 6.63 M | |||
| Z Score | 14.8 | |||
| Net Asset | 165.32 M |
About Concert Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Concert Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Concert Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Concert Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Concert Stock
If you are still planning to invest in Concert Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Concert Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |